Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NHGRI

Simulating Microarrays Using A Parameterized Model

  • Read more about Simulating Microarrays Using A Parameterized Model
US Application 60/350,326
Filed on 2002-01-18

Hematopoietic Stem Cells Regeneration of Infarcted Myocardium

  • Read more about Hematopoietic Stem Cells Regeneration of Infarcted Myocardium
US Application 60/295,804
Filed on 2001-06-06

USE OF HOMO SAPIENS CHROMOSOME 1 OPEN READING FRAME 28 (C1ORF28) IN THE DIAGNOSIS OF HYPERPARATHYROIDISM-JAW TUMOR SYNDROME (HPT-JT)

  • Read more about USE OF HOMO SAPIENS CHROMOSOME 1 OPEN READING FRAME 28 (C1ORF28) IN THE DIAGNOSIS OF HYPERPARATHYROIDISM-JAW TUMOR SYNDROME (HPT-JT)
US Application 60/378,022
Filed on 2002-05-13

Alteration of RAB38 function to modulate mammalian pigmentation

  • Read more about Alteration of RAB38 function to modulate mammalian pigmentation
US Application 60/349,929
Filed on 2002-01-18

CELL-BASED GENE SILENCING MICROARRAYS AND METHODS OF THEIR USE

  • Read more about CELL-BASED GENE SILENCING MICROARRAYS AND METHODS OF THEIR USE
US Application 60/370,970
Filed on 2002-04-08

Molecular Abnormalities On Chromosome 1q In Hutchinson-Gilford Progeria Syndrome - HGPS

  • Read more about Molecular Abnormalities On Chromosome 1q In Hutchinson-Gilford Progeria Syndrome - HGPS
US Application 60/419,541
Filed on 2002-10-18

Specific Inhibition of Gene Expression By Small Double Strands RNAS

  • Read more about Specific Inhibition of Gene Expression By Small Double Strands RNAS
US Application 60/308,640
Filed on 2001-07-30

Use of Interferon-inducible 2',5'-Oligoadenylate-dependent RNase L in The Diagnosis, Prognosis And Treatment of Cancer

  • Read more about Use of Interferon-inducible 2',5'-Oligoadenylate-dependent RNase L in The Diagnosis, Prognosis And Treatment of Cancer
US Application 60/299,664
Filed on 2001-06-20

Hematopoietic Stem Cells Regeneration of Infarcted Myocardium

  • Read more about Hematopoietic Stem Cells Regeneration of Infarcted Myocardium
US Application 60/295,803
Filed on 2001-06-06

STEM CELL MOBILIZATION LEADS TO REGENERATION OF INFARCTED MYOCARDIUM AMELIORATING CENTRICULAR PERFORMANCE IN MICE.

  • Read more about STEM CELL MOBILIZATION LEADS TO REGENERATION OF INFARCTED MYOCARDIUM AMELIORATING CENTRICULAR PERFORMANCE IN MICE.
US Application 60/258,564
Filed on 2000-12-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • …
  • Next page ››
  • Last page Last »
Subscribe to NHGRI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health